Which intervention is NOT recommended for the management of osteoporosis?

The intervention high-dose estrogen therapy is not recommended for the management of osteoporosis due to safety concerns and potential adverse effects. While estrogen can help maintain bone density, the risks associated with long-term high-dose therapy, such as increased chances of thromboembolic events and certain cancers, outweigh the benefits.

Instead, the recommended management strategies focus on the use of adequate calcium and vitamin D intake to promote bone health, engaging in weight-bearing exercises to strengthen bones and improve balance, and smoking cessation to mitigate the risk of bone density loss. These interventions build a foundation for maintaining bone strength and reducing the risk of fractures, aligning with current guidelines for osteoporosis management.